Nature Reviews Immunology 11, 658–671 (2011)
In the original version of this article, in the section under the subheading “CNS-specific NK cells in disease” on page 668, the humanized antibody daclizumab was incorrectly described as being specific for the IL-2 receptor β-chain (CD122). The corrected sentence now reads: “These findings might be relevant to the mode of action of daclizumab, a humanized antibody specific for the IL-2 receptor α-chain (CD25)”. The authors apologize for this error.
Additional information
The online version of the original article can be found at 10.1038/nri3065
Rights and permissions
About this article
Cite this article
Shi, FD., Ljunggren, HG., La Cava, A. et al. Erratum: Organ-specific features of natural killer cells. Nat Rev Immunol 11, 880 (2011). https://doi.org/10.1038/nri3116
Published:
Issue Date:
DOI: https://doi.org/10.1038/nri3116
